{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:58:59Z","timestamp":1790873939589,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T00:00:00Z","timestamp":1467936000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s12149-016-1106-7","type":"journal-article","created":{"date-parts":[[2016,7,8]],"date-time":"2016-07-08T07:42:59Z","timestamp":1467963779000},"page":"629-636","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Metformin discontinuation less than 72\u00a0h is suboptimal for F-18 FDG PET\/CT interpretation of the bowel"],"prefix":"10.1007","volume":"30","author":[{"given":"Suk Hyun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soyoung","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Sang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Sook","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,8]]},"reference":[{"key":"1106_CR1","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/RLU.0b013e318217399e","volume":"36","author":"B Bybel","year":"2011","unstructured":"Bybel B, Greenberg ID, Paterson J, Ducharme J, Leslie WD. Increased F-18 FDG intestinal uptake in diabetic patients on metformin: a matched case\u2013control analysis. Clin Nucl Med. 2011;36:452\u20136.","journal-title":"Clin Nucl Med"},{"key":"1106_CR2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00259-007-0563-6","volume":"35","author":"E Gontier","year":"2008","unstructured":"Gontier E, Fourme E, Wartski M, Blondet C, Bonardel G, Le Stanc E, et al. High and typical 18F-FDG bowel uptake in patients treated with metformin. Eur J Nucl Med Mol Imaging. 2008;35:95\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1106_CR3","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00259-009-1330-7","volume":"37","author":"T Ozulker","year":"2010","unstructured":"Ozulker T, Ozulker F, Mert M, Ozpacaci T. Clearance of the high intestinal 18F-FDG uptake associated with metformin after stopping the drug. Eur J Nucl Med Mol Imaging. 2010;37:1011\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1106_CR4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2967\/jnmt.113.132621","volume":"42","author":"DS Surasi","year":"2014","unstructured":"Surasi DS, Bhambhvani P, Baldwin JA, Almodovar SE, O\u2019Malley JP. 18F-FDG PET and PET\/CT patient preparation: a review of the literature. J Nucl Med Technol. 2014;42:5\u201313.","journal-title":"J Nucl Med Technol"},{"key":"1106_CR5","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.2214\/AJR.10.4663","volume":"195","author":"JR Oh","year":"2010","unstructured":"Oh JR, Song HC, Chong A, Ha JM, Jeong SY, Min JJ, et al. Impact of medication discontinuation on increased intestinal FDG accumulation in diabetic patients treated with metformin. AJR Am J Roentgenol. 2010;195:1404\u201310.","journal-title":"AJR Am J Roentgenol"},{"key":"1106_CR6","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1148\/radiol.09090768","volume":"254","author":"JT Abele","year":"2010","unstructured":"Abele JT, Fung CI. Effect of hepatic steatosis on liver FDG uptake measured in mean standard uptake values. Radiology. 2010;254:917\u201324.","journal-title":"Radiology"},{"key":"1106_CR7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2214\/AJR.10.4679","volume":"196","author":"G Abikhzer","year":"2011","unstructured":"Abikhzer G, Alabed YZ, Azoulay L, Assayag J, Rush C. Altered hepatic metabolic activity in patients with hepatic steatosis on FDG PET\/CT. AJR Am J Roentgenol. 2011;196:176\u201380.","journal-title":"AJR Am J Roentgenol"},{"key":"1106_CR8","first-page":"156","volume":"32","author":"Z Dostbil","year":"2013","unstructured":"Dostbil Z, Varoglu E, Serdengecti M, Kaya B, Onder H, Sari O. Evaluation of hepatic metabolic activity in non-alcoholic fatty livers on 18FDG PET\/CT. Rev Esp Med Nucl Imagen Mol. 2013;32:156\u201361.","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"1106_CR9","unstructured":"Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J. SEER survival monograph: cancer survival among adults: US SEER Program, 1988\u20132001, patient and tumor characteristics. In: National Cancer Institute, SEER Program, NIH Pub. No. 07-6215 2007. http:\/\/seer.cancer.gov\/archive\/publications\/survival\/seer_survival_mono_lowres.pdf . Accessed 2 June 2016."},{"key":"1106_CR10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2478\/raon-2013-0035","volume":"48","author":"G Treglia","year":"2014","unstructured":"Treglia G, Taralli S, Salsano M, Muoio B, Sadeghi R, Giovanella L. Prevalence and malignancy risk of focal colorectal incidental uptake detected by 18F-FDG-PET or PET\/CT: a meta-analysis. Radiol Oncol. 2014;48:99\u2013104.","journal-title":"Radiol Oncol"},{"key":"1106_CR11","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0006-2952(99)00396-2","volume":"59","author":"T Ikeda","year":"2000","unstructured":"Ikeda T, Iwata K, Murakami H. Inhibitory effect of metformin on intestinal glucose absorption in the perfused rat intestine. Biochem Pharmacol. 2000;59:887\u201390.","journal-title":"Biochem Pharmacol"},{"key":"1106_CR12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF01212553","volume":"7","author":"E Lorch","year":"1971","unstructured":"Lorch E. Inhibition of intestinal absorption and improvement of oral glucose tolerance by biguanides in the normal and in the streptozotocin-diabetic rat. Diabetologia. 1971;7:195\u2013203.","journal-title":"Diabetologia"},{"key":"1106_CR13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/00498259409043220","volume":"24","author":"C Wilcock","year":"1994","unstructured":"Wilcock C, Bailey CJ. Accumulation of metformin by tissues of the normal and diabetic mouse. Xenobiotica. 1994;24:49\u201357.","journal-title":"Xenobiotica"},{"key":"1106_CR14","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199602293340906","volume":"334","author":"CJ Bailey","year":"1996","unstructured":"Bailey CJ, Turner RC. Metformin. N Engl J Med. 1996;334:574\u20139.","journal-title":"N Engl J Med"},{"key":"1106_CR15","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1476-5381.1994.tb13128.x","volume":"112","author":"CJ Bailey","year":"1994","unstructured":"Bailey CJ, Mynett KJ, Page T. Importance of the intestine as a site of metformin-stimulated glucose utilization. Br J Pharmacol. 1994;112:671\u20135.","journal-title":"Br J Pharmacol"},{"key":"1106_CR16","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1042\/bj2620881","volume":"262","author":"L Penicaud","year":"1989","unstructured":"Penicaud L, Hitier Y, Ferre P, Girard J. Hypoglycaemic effect of metformin in genetically obese (fa\/fa) rats results from an increased utilization of blood glucose by intestine. Biochem J. 1989;262:881\u20135.","journal-title":"Biochem J"},{"key":"1106_CR17","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3748\/wjg.v12.i11.1657","volume":"12","author":"LA Drozdowski","year":"2006","unstructured":"Drozdowski LA, Thomson AB. Intestinal sugar transport. World J Gastroenterol. 2006;12:1657\u201370.","journal-title":"World J Gastroenterol"},{"key":"1106_CR18","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S1521-6918(03)00107-0","volume":"17","author":"EM Wright","year":"2003","unstructured":"Wright EM, Martin MG, Turk E. Intestinal absorption in health and disease\u2014sugars. Best Pract Res Clin Gastroenterol. 2003;17:943\u201356.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1106_CR19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2967\/jnumed.112.106666","volume":"54","author":"M Massollo","year":"2013","unstructured":"Massollo M, Marini C, Brignone M, Emionite L, Salani B, Riondato M, et al. Metformin temporal and localized effects on gut glucose metabolism assessed using 18F-FDG PET in mice. J Nucl Med. 2013;54:259\u201366.","journal-title":"J Nucl Med"},{"key":"1106_CR20","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/0006-2952(90)90136-9","volume":"39","author":"C Wilcock","year":"1990","unstructured":"Wilcock C, Bailey CJ. Sites of metformin-stimulated glucose metabolism. Biochem Pharmacol. 1990;39:1831\u20134.","journal-title":"Biochem Pharmacol"},{"key":"1106_CR21","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.cellsig.2012.04.017","volume":"24","author":"TF Chai","year":"2012","unstructured":"Chai TF, Hong SY, He H, Zheng L, Hagen T, Luo Y, et al. A potential mechanism of metformin-mediated regulation of glucose homeostasis: inhibition of Thioredoxin-interacting protein (Txnip) gene expression. Cell Signal. 2012;24:1700\u20135.","journal-title":"Cell Signal"},{"key":"1106_CR22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1096\/fj.05-4439fje","volume":"20","author":"S Oka","year":"2006","unstructured":"Oka S, Liu W, Masutani H, Hirata H, Shinkai Y, Yamada S, et al. Impaired fatty acid utilization in thioredoxin binding protein-2 (TBP-2)-deficient mice: a unique animal model of Reye syndrome. Faseb J. 2006;20:121\u20133.","journal-title":"Faseb J"},{"key":"1106_CR23","doi-asserted-by":"crossref","first-page":"e28804","DOI":"10.1371\/journal.pone.0028804","volume":"6","author":"M Shaked","year":"2011","unstructured":"Shaked M, Ketzinel-Gilad M, Cerasi E, Kaiser N, Leibowitz G. AMP-activated protein kinase (AMPK) mediates nutrient regulation of thioredoxin-interacting protein (TXNIP) in pancreatic beta-cells. PLoS One. 2011;6:e28804.","journal-title":"PLoS One"},{"key":"1106_CR24","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2967\/jnumed.108.056283","volume":"50","author":"FN Roy","year":"2009","unstructured":"Roy FN, Beaulieu S, Boucher L, Bourdeau I, Cohade C. Impact of intravenous insulin on 18F-FDG PET in diabetic cancer patients. J Nucl Med. 2009;50:178\u201383.","journal-title":"J Nucl Med"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-016-1106-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-016-1106-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-016-1106-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T18:17:44Z","timestamp":1568139464000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-016-1106-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,8]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["1106"],"URL":"https:\/\/doi.org\/10.1007\/s12149-016-1106-7","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,8]]}}}